TransMolecular's Seed Round

TransMolecular raised a round of funding on July 01, 1997.

Transmolecular is a biotechnology company targeting disorders of the central nervous system. The company is committed to discovering, developing, and commercializing targeted therapies for glioma, met…

Articles about TransMolecular's Seed Round: